Nxera Pharma Co., Ltd. (4565.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In JPY
| Market Cap | 74.66B |
| Enterprise Value | 111.67B |
| P/E Ratio | -12.77 |
| PEG Ratio | 0.13 |
| Price/Sales Ratio | 3.03 |
| Price/Book Ratio | 1.56 |
| Enterprise/Revenue | 4.12 |
| Enterprise/EBITDA | 62.48 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.23 |
| Operating Margin | -0.07 |
| Return On Assets | -0.06 |
| Return On Equity | -0.12 |
| Revenue | 29.62B |
| Revenue/Share | 365.86 |
| Gross Profit | 21.42B |
| EBITDA | -3.91B |
| Net Income | -12.53B |
| Diluted EPS | -138.8 |
| Total Cash | 17.75B |
| Total Cash/Share | 194.23 |
| Total Debt | 54.41B |
| Total Debt/Equity | 0.84 |
| Current Ratio | 2.66 |
| Book Value Per Share | 709.18 |
| 52-Week Change | 16.11 |
| 52-Week High | 1,247 |
| 52-Week Low | 723 |
| Moving Average 50 Days | 957.5 |
| Moving Average 200 Days | 928.11 |
| Average Volume | 820,806 |
| Shares Outstanding | 91.73M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 4:1 |
| Last Split Date | June 27, 2018 |